Tag: Alpenglow Biosciences

Alpenglow Biosciences and Partners Secure a Total of $24M for Development of Alpenglow’s 3D Spatial Pathology Platform

Alpenglow Biosciences and Partners Secure a Total of $24M for Development of Alpenglow’s 3D Spatial Pathology Platform

August 15, 2024 04:00 AM Pacific Daylight Time SEATTLE–(BUSINESS WIRE)–Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health…

Read More Read More

Alpenglow Biosciences has filed a notice of an exempt offering of securities to raise $4,850,000.00 in New Debt Financing.

Alpenglow Biosciences has filed a notice of an exempt offering of securities to raise $4,850,000.00 in New Debt Financing.

According to filings with the U.S. Securities and Exchange Commission, Alpenglow Biosciences is raising up to $4,850,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nicholas Reder played a…

Read More Read More